Comment on: 'Could the AREDS formula benefit patients with glaucoma?'.
作者信息
Nair Aditya, Baneke Alex J
机构信息
School of Medicine, Anglia Ruskin University, Chelmsford, UK.
Broomfield Hospital, Mid and South Essex NHS Foundation Trust, Chelmsford, UK.
出版信息
Eye (Lond). 2023 Jul;37(10):2160. doi: 10.1038/s41433-022-02279-w. Epub 2022 Nov 5.
Abstract
摘要
相似文献
1
Comment on: 'Could the AREDS formula benefit patients with glaucoma?'.
Eye (Lond). 2023 Jul;37(10):2160. doi: 10.1038/s41433-022-02279-w. Epub 2022 Nov 5.
2
Could the AREDS formula benefit patients with glaucoma?
Eye (Lond). 2022 May;36(5):918-920. doi: 10.1038/s41433-022-01956-0. Epub 2022 Jan 29.
3
Adherence of patients with age-related macular degeneration to AREDS 2-recommended nutritional supplements.
Ir J Med Sci. 2023 Dec;192(6):3163-3167. doi: 10.1007/s11845-023-03351-4. Epub 2023 Mar 27.
4
Cost-effectiveness of age-related macular degeneration study supplements in the UK: combined trial and real-world outcomes data.
Br J Ophthalmol. 2018 Apr;102(4):465-472. doi: 10.1136/bjophthalmol-2017-310939. Epub 2017 Aug 23.
5
Enhancing the efficacy of AREDS antioxidants in light-induced retinal degeneration.
Mol Vis. 2017 Oct 10;23:718-739. eCollection 2017.
6
CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration.
Ophthalmology. 2013 Nov;120(11):2317-23. doi: 10.1016/j.ophtha.2013.07.039. Epub 2013 Aug 21.
7
Ocular nutritional supplements: are their ingredients and manufacturers' claims evidence-based?
Ophthalmology. 2015 Mar;122(3):595-9. doi: 10.1016/j.ophtha.2014.09.039. Epub 2014 Nov 20.
8
Evidence-based vitamin supplements for age-related macular degeneration: an analysis of available products.
Clin Exp Optom. 2022 Nov;105(8):836-841. doi: 10.1080/08164622.2021.1989264. Epub 2021 Nov 15.
9
No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38.
Ophthalmology. 2014 Nov;121(11):2173-80. doi: 10.1016/j.ophtha.2014.05.008. Epub 2014 Jun 26.
10
Current use of dietary supplementation in patients with age-related macular degeneration.
Can J Ophthalmol. 2003 Feb;38(1):27-32. doi: 10.1016/s0008-4182(03)80005-4.
本文引用的文献
1
Could the AREDS formula benefit patients with glaucoma?
Eye (Lond). 2022 May;36(5):918-920. doi: 10.1038/s41433-022-01956-0. Epub 2022 Jan 29.
2
Association of serum retinol concentration with normal-tension glaucoma.
Eye (Lond). 2022 Sep;36(9):1820-1825. doi: 10.1038/s41433-021-01740-6. Epub 2021 Aug 12.
3
The role of intracranial pressure in glaucoma and therapeutic implications.
Eye (Lond). 2020 Jan;34(1):178-191. doi: 10.1038/s41433-019-0681-y. Epub 2019 Nov 27.
4
Isotretinoin-associated intracranial hypertension.
Ophthalmology. 2004 Jun;111(6):1248-50. doi: 10.1016/j.ophtha.2003.09.044.
5
Multivariate analysis of the risk of glaucomatous visual field loss.
Arch Ophthalmol. 1979 Aug;97(8):1455-8. doi: 10.1001/archopht.1979.01020020117005.
Zotero 插件